These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1403 related articles for article (PubMed ID: 20841605)

  • 21. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3.
    Baandrup L; Munk C; Andersen KK; Junge J; Iftner T; Kjær SK
    Gynecol Oncol; 2012 Feb; 124(2):281-5. PubMed ID: 22036987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
    Rodríguez AC; Schiffman M; Herrero R; Hildesheim A; Bratti C; Sherman ME; Solomon D; Guillén D; Alfaro M; Morales J; Hutchinson M; Katki H; Cheung L; Wacholder S; Burk RD
    J Natl Cancer Inst; 2010 Mar; 102(5):315-24. PubMed ID: 20157096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.
    Castle PE; Shaber R; LaMere BJ; Kinney W; Fetterma B; Poitras N; Lorey T; Schiffman M; Dunne A; Ostolaza JM; McKinney S; Burk RD
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):946-53. PubMed ID: 21415357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
    Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
    Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triaging women with human papillomavirus infection and normal cytology or low-grade dyskaryosis: evidence from 10-year follow up of the ARTISTIC trial cohort.
    Gilham C; Sargent A; Peto J
    BJOG; 2020 Jan; 127(1):58-68. PubMed ID: 31541495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening.
    Hashim D; Engesæter B; Baadstrand Skare G; Castle PE; Bjørge T; Tropé A; Nygård M
    Br J Cancer; 2020 May; 122(11):1715-1723. PubMed ID: 32242098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities.
    Spinillo A; Gardella B; Roccio M; Alberizzi P; Cesari S; Patrizia M; Silini E
    Cancer Causes Control; 2014 Dec; 25(12):1669-76. PubMed ID: 25296710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
    Zhang J; Zhang D; Yang Z; Wang X; Wang D
    BMC Cancer; 2020 May; 20(1):443. PubMed ID: 32429919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
    J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study.
    Wu P; Xiong H; Yang M; Li L; Wu P; Lazare C; Cao C; Gao P; Meng Y; Zhi W; Lin S; Hu J; Wei J; Ma D; Liu J; Yin P; Xing H
    Gynecol Oncol; 2019 Dec; 155(3):436-443. PubMed ID: 31604662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
    J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F; Du H; Wang C; Huang X; Wu R;
    PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
    Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
    JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
    Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
    Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear.
    Berkhof J; Bulkmans NW; Bleeker MC; Bulk S; Snijders PJ; Voorhorst FJ; Meijer CJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1268-73. PubMed ID: 16835322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
    Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
    Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
    Damgaard RK; Jenkins D; Stoler MH; de Koning M; van de Sandt M; Lycke KD; Kahlert J; Gravitt PE; Quint WGV; Steiniche T; Petersen LK; Hammer A
    Am J Obstet Gynecol; 2024 Jun; 230(6):655.e1-655.e10. PubMed ID: 38336125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion.
    Zuna RE; Wang SS; Schiffman M; Solomon D
    Cancer; 2006 Oct; 108(5):288-97. PubMed ID: 16952155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.